Pharma / Medical

In 1991 Mr Mehboob Adam, a successful owner of 5 pharmacies, identified an opportunity in the wholesale pharmaceutical industry, created by the differential pricing structures of manufacturers. It was not long before Mr Adam found himself negotiating deals on bulk purchases from manufacturers, and then passing these price advantages on to his and a few friends' pharmacies. As demand from other pharmacies increased, Mr Adam found himself more and more involved in the wholesaling side of pharmacy, and in 1992 Kassbell Pharmaceuticals was formed with the name subsequently changing to Zenith Pharmaceutical Distributors in 1998. During July 2015 Iszipharm, a 100% black owned company, bought over the entire shares of Zenith Pharmaceutical Distributors. Zenith is now wholly owned by Iszipharm with Mr E Bhorat, Mr I Bhorat and Ms Z Hendricks as its shareholders and directors. All staff employed at Zenith are from previously disadvantaged backgrounds and have experience in the pharmaceutical industry. Zenith is licenced with the Department of Health and registered with the South African Pharmacy Council and Medicine Control Council of South Africa and complies with regulations set out by these statutory bodies. While Zenith previously focussed only on supplying ethicals, due to customer demand we have recently increased our surgical and front shop lines. Zenith supplies Pharmaceuticals to retail pharmacies, private hospitals, doctors and other registered healthcare professionals. We specialize in branded and generic medication. Zenith is the preferred supplier to the Melomed Private Hospital Group comprising of 4 hospitals and a private clinic in the Cape Town region - with a 5th hospital opening in December 2015. We are confident that this partnership will enhance our presence in the hospital industry. Zenith operates from its licenced premises in Athlone Industria. Being based in Cape Town, South Africa, our focus is primarily on servicing our 500+ customers based in the Western Cape. The Responsible Pharmacist is Mr Anvar Vasta, who is assisted by Ms Lamees Mohamed. The buying department comprises of dedicated ethical and surgical buyers under the management of the chief buyer Mr Haroon Saloojee, who is a qualified Pharmacist. Buyers ensure maintaining good stock levels and meeting the needs of our valued customers.

Compounded medications are prepared as per the doctor’s prescription and formulated in the exact strength and form needed by the patient. This allows doctors and pharmacists to customize a medication that meets the patient’s specific requirements. Historically, all medicines were compounded, but with mass-produced drugs this is no longer the case. A ‘one-size-fits-all’ approach does not, however, always meet the needs of patients, and compounding pharmacists provide a solution for this. Modern technology and innovation has revived the historic art and science of compounding pharmaceuticals. The Fagron compounding pharmacies in Cape Town (Rausa-kem), Johannesburg (Dynaceuticals) and George (Mar-Kem) have served doctors and patients since 1995. Fagron South Africa is well established as a respected partner and leader in the pharmaceutical compounding industry. Fagron entered the South African market through acquisition of key compounding pharmacies in Cape Town, George and Johannesburg. In 2014, Fagron acquired Dynaceuticals, a compounding pharmacy in Gauteng, which is headed by three dynamic professionals. In 2015, Fagron acquired Rausa-kem, which is headed by Professor Reinhard Uebel with 20 years of sterile compounding experience, Reakiri, the marketing and sales arm of Rausa-kem, and MarKem, a sterile compounding pharmacy in George. This powerful combination has created a unique, national organisation serving both doctors and patients all over the country. Our team of pharmacists is headed by Professor Reinhard Uebel, who graduated with a BPharm in 1982 and completed his PhD in 1994. He lectured pharmacology at the University of Stellenbosch and Pharmaceutics at UWC. Professor Uebel is the author of a number of research publications. Fagron South Africa compounds high-quality, cost-effective, customised, proven formulations of medications that are not available from a pharmaceutical drug company.

Key Oncologics (Pty) Ltd is a South African pharmaceutical company that primarily focuses on the treatment of cancer and allied diseases. The company was founded in 1998 representing international companies that do not have an independent presence in South Africa. Over the years our product profile has grown from a single product to a comprehensive portfolio. We have also diversified into biologics and are in the process of building a generic portfolio. In moving forward Key Oncologics will continue to seek options for patients to live longer and live better. Key Oncologics (Pty) Ltd has experience in registering, marketing, selling and distributing cancer products in the South African market. We also have a clinical trial division with the necessary infrastructure to conduct Oncology Clinical Trials according to GCP.

Hersol Manufacturing Laboratories is a fully licensed and registered pharmaceutical manufacturing company and was founded in 1980. Today Hersol is one of the leading Pharmaceutical Contract Manufacturing Companies within the South African Market. Hersol specialises in the development and manufacture of Complementary Medicines, Nutritional Supplements and Pharmaceuticals. Hersol prides itself on producing quality products through a carefully managed Total Quality Management System governing all activities, especially so as to lead the way in the Complementary Medicines and Nutritional Supplement market. As a result of the integrated Total Quality Management system, embracing first and foremost, Good Manufacturing Practices (GMP) and strict Quality Control Procedures, the best quality of both raw materials and finished product is ensured. This facility complies with the Medicine Control Council (MCC) Code of Good Manufacturing Practice (GMP), a standard of manufacturing excellence recognized throughout the Industry. Hersol maintains a watchful eye on world trends and then improves and innovates to deliver leading edge products to its customer base. This intimate market knowledge is gained through regular travel by Hersol’s Management team to major world markets. The company has acquired a reputation for consistent good quality, price, service and delivery, which is indicated by the fact that we hold a full pharmaceutical manufacturing license, which is re-assessed regularly by the South African Medicine Control Council. With Hersol manufacturing large volumes of supplements the R & D (Research and Development) department is an important contributor of new ideas and concepts that potentially add value to customers’ businesses. Close collaboration with raw material suppliers ensures that the very latest and highest quality ingredients are available for incorporation into prototype formulations, further adding value to the supply chain.

To ensure achievement of set operational objectives and to ensure desired business growth. Our current business is unified, adopting the traditional sales & marketing management styles. Embedded in this structure are Pharmaceutical and Veterinary business arms structured into territorial markets for ease of management and control. The Nigerian market and ECOWAS markets are thus similarly structured into districts and regions where Neimeth’s products are distributed. The Pharmaceuticals business distributes: Ethical Products – comprising of Neimeth branded ethical products including our flagship home grown product CIKLAVIT for the management of sickle cell disease. In addition products such as Normoretic, flexodene, Tiocosid, etc and new branded generics are part of the portfolio. Consumer Product – comprising 15 major product groups divided into 39 presentations. High volume products like NCP, Pyrantrin, Obron – 6, Homtamin G and Pancemol are included as part of consumer products portfolio. Veterinary Business  Neimeth is now poised to re-enter the lucrative Nigerian Animal Health business, which has very robust volume and profit potentials. We expect to regain a controlling market share in a few years. We have introduced our own brand of poultry and large animal range of anthelmintics, as well as production enhancing medicaments. We will also enter into strategic alliances in key disease areas that show great business potentials. Ecowas Business Neimeth is firmly on ground in the Anglophone West African Countries of Ghana, Sierra Leone, Liberia and the Gambia. Our key products like Ciklavit, Homtamin G, NCP have been registered there and are in rising demand. Before the brand name Neimeth International Pharmaceuticals Plc.,the company had operated in Nigeria for 40 years, manufacturing, marketing, and distributing Pfizer brands of pharmaceutical and veterinary products in tablets, capsules, ointment/cream, powder, injectables, and oral liquid forms. During the 40 year period (1957-1997), the company established the first pharmaceutical manufacturing plant in Nigeria at Aba, which was destroyed during the Nigerian civil war. It then set up and opened the most modern pharmaceutical plant in the West African sub-region in 1976 at Oregun, Lagos. These represent great milestones for a company that started as a trading venture in 1957 at a location in Ebute Metta, Lagos. We are committed to providing the opportunity for leadership at all levels on our organization, the pharmaceutical industry and indeed the Nation.